HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitative electron microscopic analysis of changes in peroxisomes and endoplasmic reticulum induced in mice during hepatocarcinogenesis by diethylnitrosamine promoted by di(2-ethylhexyl)phthalate or phenobarbital.

Abstract
Histochemical studies have shown that basophilic adenomas and carcinomas develop from basophilic foci in mice initiated with N-nitrosodiethylamine (DEN) and promoted by di(2-ethylhexyl)phthalate (DEHP), whereas eosinophilic liver tumors promoted by phenobarbital (PhB) arose from eosinophilic foci. In this experiment, the ultrastructure of tumorous and nontumorous areas of the liver from these two groups of mice was analyzed by quantitative morphometric methods. It is shown that nontumorous liver in DEN- and DEHP-treated mice demonstrate a pronounced proliferation of peroxisomes that is also present in liver tumors induced by DEHP alone but not in liver tumors after DEN initiation and DEHP promotion. Initiation with DEN and promotion with PhB resulted in pronounced proliferation of smooth endoplasmic reticulum (ER) in both tumorous and nontumorous liver, whereas the number of peroxisomes remained unchanged.
AuthorsH M Schuller, J M Ward
JournalJournal of experimental pathology (J Exp Pathol) Vol. 1 Issue 4 Pg. 287-94 ( 1984) ISSN: 0730-8485 [Print] United States
PMID6599940 (Publication Type: Journal Article)
Chemical References
  • Phthalic Acids
  • Diethylnitrosamine
  • Diethylhexyl Phthalate
  • Phenobarbital
Topics
  • Animals
  • Diethylhexyl Phthalate
  • Diethylnitrosamine
  • Endoplasmic Reticulum (ultrastructure)
  • Liver Neoplasms, Experimental (chemically induced, ultrastructure)
  • Male
  • Mice
  • Microbodies (ultrastructure)
  • Microscopy, Electron
  • Mitochondria, Liver (ultrastructure)
  • Phenobarbital
  • Phthalic Acids

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: